Cost-effectiveness analysis has to consider all available evidence when informing inputs. Issue 3 (4th March 2021)

Record Type:: Journal Article
Title:: Cost-effectiveness analysis has to consider all available evidence when informing inputs. Issue 3 (4th March 2021)
Main Title:: Cost-effectiveness analysis has to consider all available evidence when informing inputs
Authors:: Alvarez, Fabián P.
Petitjean, Audrey
Nealon, Joshua
Hollingsworth, Rosalind
López-Belmonte, Juan Luis
Abstract:
Is Part Of:: Human vaccines & immunotherapeutics. Volume 17:Issue 3(2021)
Journal:: Human vaccines & immunotherapeutics
Issue:: Volume 17:Issue 3(2021)
Issue Display:: Volume 17, Issue 3 (2021)
Year:: 2021
Volume:: 17
Issue:: 3
Issue Sort Value:: 2021-0017-0003-0000
Page Start:: 694
Page End:: 695
Publication Date:: 2021-03-04
Subjects:: Influenza -- vaccination -- Spain -- quadrivalent influenza vaccine (QIV) -- cost-effectiveness -- cell-based vaccines -- egg-based vaccines
Vaccines -- Periodicals
615.372
Journal URLs:: http://www.tandfonline.com/toc/khvi20/current ↗
http://www.tandfonline.com/ ↗
DOI:: 10.1080/21645515.2020.1799670 ↗
Languages:: English
ISSNs:: 2164-5515
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4336.468655
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16366.xml